254 related articles for article (PubMed ID: 6874888)
61. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
[TBL] [Abstract][Full Text] [Related]
62. Glucagon-37 (oxyntomodulin) and glucagon-29 (pancreatic glucagon) in human bowel: analysis by HPLC and radioreceptorassay.
Munck A; Kervran A; Marie JC; Bataille D; Rosselin G
Peptides; 1984; 5(3):553-61. PubMed ID: 6473171
[TBL] [Abstract][Full Text] [Related]
63. Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy.
Tanjoh K; Tomita R; Fukuzawa M; Hayashi N
Hepatogastroenterology; 2003; 50(50):535-40. PubMed ID: 12749267
[TBL] [Abstract][Full Text] [Related]
64. Bombesin-like immunoreactivity in human gastrointestinal tract.
Price J; Penman E; Wass JA; Rees LH
Regul Pept; 1984 Sep; 9(1-2):1-10. PubMed ID: 6505289
[TBL] [Abstract][Full Text] [Related]
65. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
Holst JJ; Sørensen TI; Andersen AN; Stadil F; Andersen B; Lauritsen KB; Klein HC
Scand J Gastroenterol; 1979; 14(2):205-7. PubMed ID: 432544
[TBL] [Abstract][Full Text] [Related]
66. Morphologic and physiologic studies of canine ileal enteroglucagon-containing cells in short-term culture.
Buchan AM; Barber DL; Gregor M; Soll AH
Gastroenterology; 1987 Oct; 93(4):791-800. PubMed ID: 2887480
[TBL] [Abstract][Full Text] [Related]
67. [Pancreatic glucagon and enteroglucagon in the plasma of patients with liver cirrhosis].
Kasperska-Czyzykowa T
Pol Arch Med Wewn; 1983; 69(4-5):315-23. PubMed ID: 6356055
[No Abstract] [Full Text] [Related]
68. Distribution and molecular forms of glucagon-like peptide in the dog.
Suda K; Takahashi H; Fukase N; Manaka H; Tominaga M; Sasaki H
Life Sci; 1989; 45(19):1793-8. PubMed ID: 2593768
[TBL] [Abstract][Full Text] [Related]
69. The effect of hypophysectomy and hypophysis-transplantation on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in depancreatized dogs.
Yoshida T; Kondo M
Endocrinol Jpn; 1980 Feb; 27(1):77-81. PubMed ID: 6248336
[TBL] [Abstract][Full Text] [Related]
70. The effect of pancreatic acinar atrophy upon the concentration of vasoactive intestinal polypeptide, substance P, somatostatin and glucagon in the pancreas and gastrointestinal tract of the rat.
Ballmann M; Fölsch UR; Conlon JM
Digestion; 1985; 32(1):70-5. PubMed ID: 2410316
[TBL] [Abstract][Full Text] [Related]
71. Glucagon- and glicentin-immunoreactive cells in the human digestive tract.
Garaud JC; Eloy R; Moody AJ; Stock C; Grenier JF
Cell Tissue Res; 1980; 213(1):121-36. PubMed ID: 7006827
[TBL] [Abstract][Full Text] [Related]
72. Neurohormonal peptides in the gut of the Atlantic hagfish (Myxine glutinosa) detected using antisera raised against mammalian regulatory peptides.
Conlon JM; Falkmer S
Gen Comp Endocrinol; 1989 Nov; 76(2):292-300. PubMed ID: 2480267
[TBL] [Abstract][Full Text] [Related]
73. Distribution of enteroglucagon- and polypeptide YY-immunoreactive cells in the gastrointestinal tract of the white-belly opossum (Didelphis albiventris).
Barbosa AJ; Nogueira JC; Penna FJ; Polak JM
Histochemistry; 1987; 88(1):37-40. PubMed ID: 3325477
[TBL] [Abstract][Full Text] [Related]
74. Influence of somatostatin and bombesin on plasma enteroglucagon and cell proliferation after intestinal resection in the rat.
Sagor GR; Ghatei MA; O'Shaughnessy DJ; Al-Mukhtar MY; Wright NA; Bloom SR
Gut; 1985 Jan; 26(1):89-94. PubMed ID: 2856910
[TBL] [Abstract][Full Text] [Related]
75. Regulatory peptides (glucagon, somatostatin, substance P, and VIP) in the brain and gastrointestinal tract of Ambystoma mexicanum.
Conlon JM; Ballmann M; Lamberts R
Gen Comp Endocrinol; 1985 Apr; 58(1):150-8. PubMed ID: 2580753
[TBL] [Abstract][Full Text] [Related]
76. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition.
Hayakawa T; Kondo T; Okumura N; Nagai K; Shibata T; Kitagawa M
Am J Gastroenterol; 1989 May; 84(5):523-6. PubMed ID: 2655436
[TBL] [Abstract][Full Text] [Related]
77. Presence of glucagon-(1-21)-Like immunoreactive substance in the dog small intestinal mucosa.
Itoh H; Namba M; Watanabe N; Ohara T; Matsuyama T; Komatsu R; Shinomura Y; Kono N; Tarui S
Biochem Biophys Res Commun; 1989 Dec; 165(3):1010-7. PubMed ID: 2610678
[TBL] [Abstract][Full Text] [Related]
78. The influence of an intact pylorus on postprandial enteroglucagon and neurotensin release after upper gastric surgery.
Sagor GR; Ghatei MA; McGregor GP; Mitchenere P; Kirk RM; Bloom SR
Br J Surg; 1981 Mar; 68(3):190-3. PubMed ID: 7470823
[TBL] [Abstract][Full Text] [Related]
79. Responses of python gastrointestinal regulatory peptides to feeding.
Secor SM; Fehsenfeld D; Diamond J; Adrian TE
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13637-42. PubMed ID: 11707600
[TBL] [Abstract][Full Text] [Related]
80. The effect of altered luminal nutrition on cellular proliferation and plasma concentrations of enteroglucagon and gastrin after small bowel resection in the rat.
Sagor GR; Al-Mukhtar MY; Ghatei MA; Wright NA; Bloom SR
Br J Surg; 1982 Jan; 69(1):14-8. PubMed ID: 7053795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
